Contract 75A50122F61001
Battelle Memorial Institute · Department Of Health And Human Services · February 9, 2022
Battelle Memorial Institute was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on February 9, 2022 for $12.26 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Columbus, OH. This is a task or delivery order issued under parent IDIQ 75A50122D00007. The contract has been modified 34 times since the base award It uses cost-plus contract pricing. The most recent modification was on January 20, 2026.
Contract details
- PIID
- 75A50122F61001
- Parent IDIQ
- 75A50122D00007
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Columbus, OH
- First action
- February 9, 2022
- Latest action
- January 20, 2026
Description
INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT COSTS, NECESSARY TO COMPLETE THE REMAINI
Modification timeline
-
January 20, 2026Mod P00010INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT$0
-
December 17, 2025Mod P00002THE PURPOSE OF THIS MODIFICATION IS ACTIVATE IPP.$-2.2K
-
November 24, 2025Mod P00009INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT$0
-
June 13, 2024Mod P00008INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT$306.3K
-
June 3, 2024Mod P00007INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT$0
-
March 7, 2024Mod P00006INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT$180.1K
-
December 14, 2023Mod P00001CLOSEOUT OF TASK ORDER.$0
-
November 3, 2023Mod P00005INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT$0
-
October 3, 2023Mod P00003SUPPORT NON-CLINICAL IMMUNOGENICITY STUDIES OF SARS-COV-2 MICRONEEDLE PATCH VACCINES CANDIDATES IN A SMALL-ANIMAL MODEL$0
-
September 28, 2023Mod P00004INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT$974.7K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50122F61001?
Contract 75A50122F61001 is a federal contract awarded to Battelle Memorial Institute by Department Of Health And Human Services on February 9, 2022 for $12.26 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 34 times since the base award.
Who won contract 75A50122F61001?
Battelle Memorial Institute won contract 75A50122F61001 from Department Of Health And Human Services.
How much is contract 75A50122F61001 worth?
Contract 75A50122F61001 has obligated $12.26 million to date.